New Delhi:

Around 26 per cent of cancer patients in India have tumours in the head and neck, and there is an upward trend of such cases in the country, a study has found.

The findings of the study, conducted on 1,869 cancer patients across the country, were released on the World Head and Neck Cancer Day observed on Saturday.

Cancer Mukt Bharat Foundation, a Delhi-based non-profit organisation, conducted the study by collating data from calls received on its helpline number from March 1 to June 30.

Dr. Ashish Gupta, a senior oncologist who is heading the Cancer Mukt Bharat Campaign in India, said that India is seeing surge in head and neck cancer cases, especially among young men, due to increased tobacco consumption and human papillomavirus (HPV) infection.

“Around 80-90 pc of oral cancer patients have been found to use tobacco in some form, be it smoking or chewing. Most of the head and neck cancer are preventable, unlike other cancers for which the reason is unknown. It is a preventable cancer that can be prevented with lifestyle modification.

“There is a need to raise awareness to quit tobacco and early check-ups for early pickup of the disease,” Gupta said.

In India, nearly two-thirds of cancer cases are detected late likely due to low adoption of proper screening, he said.

Gupta added that the Cancer Mukt Bharat campaign aims to reduce the incidence and impact of cancer on individuals and communities through education and early detection.

“If found early in stages one or two, most head and neck cancers are curable in more than 80 pc of patients. In the field of cancer treatment, we get new medicines almost every week which can treat cancer in better way leading to better outcomes and good quality of life.

“A combination of surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy can be used for treating head and neck cancer. Latest cancer treatment has evolved to prioritize not just curing the disease, but also ensuring a good quality of life for survivors,” he said.

Under the Cancer Mukt Bharat Campaign, a free national helpline number (93-555-20202) was launched recently, which is operational from 10 am to 5 pm from Monday to Saturday.

Cancer patients can call on this number to speak to leading oncologists directly or even do a video call to discuss about their treatment without paying any fees.

Head and neck cancer was closely followed by gastrointestinal cancers which was 16 per cent. Fufteen per cent cancers in India re breast cancers and and blood cancers make up 9 per cent of them.

These data are in line with the latest GLOBOCAN data — a database that gives global cancer statistics — on India. GLOBOCON data is part of International Agency for Research on Cancer’s Global Cancer Observatory.

India is expected to have 2.1 million new cancer cases by 2040, a big jump from the numbers in 2020, as per a recent GLOBOCAN report.
 

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

New Delhi:

The government makes all efforts to ensure affordable and accessible treatment is available for cancer patients amid a rise in cases in India, Health Minister JP Nadda said today.

Replying to supplementary questions during Question Hour in the Lok Sabha, Mr Nadda said the government made all efforts to ensure that affordable and accessible treatment was available to the patients.

“The number of cancer cases is going up, it is increasing by almost 2.5 per cent every year,” Mr Nadda said.

In men, cases of oral and lung cancer are on the up while more women are getting breast cancer, he added.

More than 15.5 lakh cancer cases are being registered every year, Mr Nadda said.

“There is a list of 131 essential cancer medicines, which are in Schedule 1, (that) are monitored and (their) pricing is decided by the government. These are the commonly used medicines,” Mr Nadda said.

He said patients cumulatively saved around Rs 294 crore due to this price control.

“There are 28 combinations, which are not in this list but the NPPA (National Pharmaceutical Pricing Authority) and the government have controlled their pricing as well,” he said.

“We have tried to make cancer drugs affordable,” he added.

Responding to another question on healthcare infrastructure, Mr Nadda said the government was apprised of the matter and expansion of medical colleges were happening so that there could be more doctors.

“There should be a balance in quality and quantity of medical education. We are trying to go as fast as we can but, at the same time, (we) do not want to compromise on the quality of medical doctors,” he said.

Mr Nadda informed the House that the number of medical colleges had gone up from 387 in 2014 to 731 at present while the number of MBBS seats rose from 51,348 seats to 1,12,112 (1.12 lakh) during the same period.

The number of postgraduate seats for medical students has gone up from 31,185 in 2014 to 72,627 at present, he added.
 

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)